|
시장보고서
상품코드
1463835
여드름 치료제 시장 : 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 보고서 : 치료 클래스별, 제형별, 유형별, 여드름 유형별, 유통 채널별, 지역별Acne Medication Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel, and Geography |
||||||
세계의 여드름 치료제 시장은 2022년 77억 7,400만 달러로 평가되었고, 2030년에는 118억 달러에 이를 것으로 예측됩니다. 이 시장은 2022년부터 2030년까지 CAGR 5.40%로 성장할 것으로 추정됩니다.
이 보고서에 소개된 여드름 치료제 시장 예측은 이 시장 지역의 이해 관계자가 성장 전략을 계획하는 데 도움이 됩니다. 시장 성장을 가속하는 주요 요인은 심각한 여드름 문제의 유병률 증가와 신약 출시입니다. 그러나 여드름 약물과 관련된 부작용은 여드름 약물 시장의 성장을 제한합니다. 또한, 여드름 치료제 시장 동향은 유기적이고 자연적인 치료에 대한 필요성 증가를 포함합니다.
여드름 치료제 시장 시장 기회
여드름 치료제 시장에 첨단 기술과 데이터 주도형 접근법을 채택함으로써 연구 개발의 새로운 길이 열립니다. 환자 데이터를 수집하고 분석함으로써 연구자는 여드름의 근본 원인에 대한 귀중한 인사이트를 얻을 수 있으며, 치료 반응의 패턴과 동향을 확인하고 치료 중재를 위한 새로운 잠재적 표적을 발견할 수 있습니다. 이를 통해 신규 약물, 혁신적인 치료 전략, 여드름 환자의 다양한 요구에 맞는 보다 개인화된 스킨케어 제품의 개발을 추진할 수 있습니다. 인공지능(AI), 머신러닝 알고리즘, 유전자 검사 및 기타 최첨단 도구를 활용하여 건강 관리 제공 업체는 엄청난 데이터를 분석하고 환자별 피부 상태, 유전 적 소인, 라이프 스타일 요인, 치료 반응을 더 깊이 이해할 수 있게 되었습니다. 이 개인화된 접근법을 통해 각 환자의 요구를 충족시키기 위해 특별히 고안된 맞춤형 치료 계획을 수립할 수 있습니다.
2021년 3월 Thorne HealthTech의 자회사에서 건강 인텔리전스 기업인 Onegevity는 미용 및 퍼스널케어 제품의 세계 최고 제조업체 중 하나인 유니레버와 제휴하여 여드름 개입 및 치료에 대한 보다 개별화된 접근이 가능했습니다. 이 과학적 공동 연구는 멀티오믹스(다른 생물학적 분야의 통합)의 가능성을 조사하고 여드름 치료에 대한 개별화 접근을 가능하게 하는 것을 목표로 합니다. 이 공동 연구는 사람의 건강에 영향을 미치는 수십억 개의 생물학적 특성을 평가할 수 있도록 Onegevity의 AI와 머신러닝 기능을 활용하여 맞춤형 여드름 치료 계획을 가능하게 하는 새로운 진단 모델을 만드는 것을 목표로 합니다. 개인화된 치료 계획은 여드름 치료제에 대한 반응에 영향을 줄 수 있는 환자별 특성과 요인을 고려하여 치료 효과를 최적화하는 데 도움이 됩니다. 이러한 환자별 데이터를 바탕으로 의료 서비스 제공업체는 특정 개인에게 더 효과적일 수 있는 치료법을 처방할 수 있습니다. 이로 인해 여드름 치료가 성공할 확률이 높아지고 부작용과 유해 반응의 가능성이 줄어들어 환자 결과가 개선되고 만족도가 향상됩니다. 따라서 개인화된 치료 계획을 설계하기 위한 첨단 기술과 데이터 중심 접근 방식의 통합은 여드름 치료제 시장에서 혁신, 성장 및 환자 결과 개선을 위한 큰 기회를 창출하고 있습니다.
여드름 치료제 시장을 방해하는 요인
경구 항생제, 레티노이드, 호르몬 요법을 포함한 많은 전통적인 전신성 여드름 치료제는 피부 건조, 자극, 광선 과민증, 위장 불쾌감, 드물게 심한 전신 부작용 등 다양한 잠재력 부작용이 동반됩니다. 이러한 잠재적인 부작용은 환자와 건강 관리 제공업체 사이에 우려를 일으키고, 특정 여드름 치료제의 채택, 특히 장기간 사용에 대한 망설임을 초래합니다. 부작용은 또한 치료 어드히어런스의 부족으로 이어질 수 있으며, 견딜 수 없거나 바람직하지 않은 부작용으로 인해 특정 약물을 중단하거나 피할 수 있습니다. 결과적으로 소비자는 부작용을 최소화하면서 효능을 선호하는 고급 제형 및 치료법에 대한 기울기를 보여주고 신규, 더 내약한, 더 나은 여드름 치료제에 끊임없이 아니 필요가 가져옵니다. 따라서 여드름 치료제와 관련된 부작용은 여드름 치료제 시장의 성장을 제한합니다.
여드름 치료제 시장 부문별 개요
2022년 여드름 치료제 시장은 치료 클래스별로 레티노이드 부문이 가장 큰 점유율을 차지하였으며, 이 부문은 2022년부터 2030년까지 높은 CAGR을 나타낼 것으로 예측되고 있습니다. 의사의 처방전이 없으면 구입할 수 없는 레티노이드는 비타민 A를 주성분으로 하고 있으며, 레티놀과 비슷한 기능을 하지만 여드름 치료에 훨씬 강력하고 더 성공적입니다. 레티노이드에는 경구 캡슐 및 외용 요법이 있습니다. 트레티노인, 아다팔렌, 이소트레티노인은 잘 알려진 레티노이드이며, 이소트레티노인의 경구 제형은 로아큐탄이라고도 합니다. 레티노이드는 환자의 체중 1kg당 외용약에서는 0.1-1%, 내복약에서는 0.5-1mg의 용량으로 처방되는 경우가 많습니다.
투약 형태에 따라 여드름 치료제 시장은 외용약과 내복약으로 분류됩니다. 2022년 여드름 치료제 시장에서 외용제 부문은 가장 큰 점유율을 차지했습니다. 이 분야는 2022년부터 2030년까지 시장에서 높은 CAGR을 나타낼 것으로 예측됩니다. 외용 제제는 여드름 관리 및 치료에 중요한 역할을 하며 환부의 피부에 직접 활성 성분을 전달합니다. 다양한 유형의 여드름 외용제에는 젤, 크림, 로션, 폼, 용액 등이 있으며, 각각이 특정 여드름 우려와 피부 유형에 대응하도록 조정됩니다. 이러한 제형은 일반적으로 레티노이드, 벤조일 퍼옥시드, 살리실산, 항생제 등의 성분을 포함하며, 각각이 여드름 송풍과의 싸움에서 명확한 역할을 합니다.
유형별로 보면 세계의 여드름 치료제 시장은 처방약과 시판약으로 분류됩니다. 처방약 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다. 피부과 의사 또는 건강 관리 제공업체는 일반적으로 개인의 여드름 유형, 중증도 및 이전 치료에 대한 반응성을 철저히 평가한 후 약물을 처방합니다. 처방되는 여드름 치료제에는 국소 치료제, 내복제, 병용 요법, 특정 여드름 우려에 대처하기 위해 조정된 특수 제제 등 다양한 옵션이 있습니다. 처방약은 중등도에서 심각한 여드름 환자를 대상으로 대상을 좁힌 강력한 솔루션을 제공합니다.
여드름 치료제 시장은 형태에 따라 소매점, 약국, 약점 등으로 구분됩니다. 2022년에는 약국 및 약점 부문이 더 큰 시장 점유율을 차지했습니다. 약국 및 약 전문점은 그 액세스의 용이성, 프라이버시의 보호,(개인의에 비해)합리적인 가격에 의해 의료 서비스, 소모품, 지식의 중요한 공급원이 되고 있습니다. 최근, 약국 및 약 전문점은 다양한 병이나 병리의 관리를 지원하는 것에 의해 건강을 증진시키는 능력으로, 많은 나라에서 인지되고 있습니다. 약국 및 약 전문점에는 종종 지식이 풍부한 직원이 있으며 고객의 개인적인 피부 유형과 고민에 따라 적절한 여드름 치료제를 선택할 수 있도록 안내합니다.
여드름 치료제 시장 : 지리적 개요
여드름 치료제 시장의 조사 범위는 북미, 유럽, 아시아태평양, 중동, 아프리카, 중남미입니다. 2022년에는 북미가 세계 여드름 치료제 시장에서 가장 큰 점유율을 차지했습니다.
여드름은 찌꺼지, 기름, 피지, 오래된 각질이 모근에 막혀서 발생하는 피부 질환입니다. 미국 피부과 학회에 따르면 여드름은 미국에서 가장 확산되는 질병으로 매년 5천만 명의 미국인이 여드름으로 고통받고 있습니다. 미국인의 여드름 발병률 증가와 이에 따른 다양한 혁신적인 여드름 치료제의 출시로 이 나라의 여드름 치료제 시장이 확대될 것으로 예측됩니다. 게다가 몸에 익숙해지고, 피부 건강, 외모에 대한 주목이 높아지고 있는 것도 여드름 치료제 수요를 뒷받침하고 있습니다. 기술의 진보와 연구를 통해 효능이 개선되고 부작용이 최소화된 혁신적인 여드름 치료 제품이 개발되어 미국에서 여드름 치료제 시장의 성장에 더욱 기여하고 있습니다.
아시아태평양은 2022년부터 2030년까지 가장 높은 CAGR을 나타낼 것으로 추정됩니다. 이 지역은 예측 기간 동안 가장 빠른 CAGR을 나타낼 것으로 예상됩니다. 아시아태평양에서는 중국이 여드름 치료제의 최대 시장입니다. 중국 여드름 치료제 시장은 다양한 요인에 의해 추진되고 있습니다. 특필해야 할 것은 AI를 활용한 원격 의료의 보급이 피부과 의료에 혁명을 가져오고, 치료에 대한 액세스를 개선하고, 같은 치료에 있어서 더 나은 개인화를 제공하고 있다는 것입니다. AIDERMA는 AI에 의한 피부 환자의 진단과 치료를 위한 중국 최초의 종합 플랫폼입니다. 상담, 지속적인 교육, 지원된 진단 및 치료는 AIDERMA의 주요 제공물입니다. 90가지 이상의 일반적인 피부병이 진단 및 치료를 돕기 위해 제공됩니다. 이것은 진단과 잠재적인 치료 정책을 제공하는 간단한 절차라고 주장합니다. 중국의 의사가 건선, 습진, 아토피 피부염을 진단할 수 있는 애플리케이션인 AIDDA에는 7,000명 이상의 임상의가 등록하고 있습니다.
여드름 치료제 시장에 관한 보고서 작성 시 참고한 주요 1차 및 2차 정보로는 세계은행 데이터, 국민보건서비스(NHS), EMA(유럽의약청), WHO(세계보건기구) 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 여드름 치료제 시장 상황
- PEST 분석
- 외용약 및 내복약의 가격 분석
- 여드름 치료를 받는 환자층
제5장 여드름 치료제 시장 : 주요 시장 역학
- 여드름 치료제 시장 : 주요 시장 역학
- 주요 시장 성장 촉진요인
- 중증 여드름의 유병률 증가
- 신약의 발매
- 주요 시장 성장 억제요인
- 여드름 치료제와 관련된 부작용
- 주요 시장 기회
- 최첨단 기술 및 데이터 주도형 전략에 기초한 맞춤형 치료 프로그램
- 향후의 동향
- 유기농 자연 치료에 대한 요구 증가
- 성장 촉진요인 및 억제요인의 영향
제6장 여드름 치료제 시장 : 세계 시장 분석
제7장 여드름 치료제 시장 분석 : 치료 클래스별
- 레티노이드
- 과산화벤조일
- 항생제
- 살리실산
- 기타
제8장 여드름 치료제 시장 분석 : 제형별
- 외용약
- 경구약
제9장 여드름 치료제 시장 분석 : 유형별
- 처방약
- 시판약
제10장 여드름 치료제 시장 분석 : 여드름 유형별
- 비염증성 여드름
- 염증성 여드름
제11장 여드름 치료제 시장 분석 : 유통 채널별
- 약국 및 드럭스토어
- 소매점
- 전자상거래
제12장 여드름 치료제 시장 : 지역별 분석
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
- 중동 및 아프리카
- 사우디아라비아
- 남아프리카
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
제13장 여드름 치료제 시장 : 업계 정세
- 여드름 치료제 시장의 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
- 팔마피엘 및 타사 여드름 치료제의 제품 비교
제14장 기업 프로파일
- Teva Pharmaceutical Industries Ltd
- Mayne Pharma Group Ltd
- Almirall SA
- Johnson & Johnson
- Sun Pharmaceutical Industries Ltd
- Bausch Health Companies Inc
- Centro Internacional de Cosmiatria SA de CV
- Galderma SA
- Pfizer Inc
- GSK Plc
- Viatris Inc
- Somar Sapi De CV
- Pierre Fabre SA
- Carnot Technologies
- Italmex SA
제15장 부록
AJY 24.04.30The global acne medication market is expected to reach US$ 11.80 billion in 2030 from US$ 7.774 billion in 2022. The market is estimated to grow with a CAGR of 5.40% from 2022 to 2030.
The acne medication market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. Key factors driving the market growth are the increasing prevalence of severe acne problems and the launch of novel drugs. However, side effects associated with acne medication limit the growth of the acne medication market. Moreover, acne medication market trends include the upsurge in need for organic and natural treatments.
Market Opportunities of Acne Medication Market
Adopting advanced technologies and data-driven approaches in the acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to better understand a patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.
In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the acne medication market.
Factor Hampering Acne Medication Market
Many traditional and systemic acne treatments, including oral antibiotics, retinoids, and hormonal therapies, are associated with a range of potential adverse effects, including skin dryness, irritation, photosensitivity, gastrointestinal discomfort, and, in rare cases, more severe systemic side effects. These potential adverse reactions have raised concerns among patients and healthcare providers, leading to hesitance in the adoption of certain acne medications, particularly for long-term use. Side effects also result in the lack of treatment adherence, as individuals may opt to discontinue or avoid specific medications due to intolerable or undesirable side effects. Consequently, consumers show an inclination toward advanced formulations and treatment modalities that prioritize efficacy while minimizing adverse reactions, introducing a constant need for novel, more tolerable, and better-tolerated acne medications. Thus, side effects associated with acne medication limit the growth of the acne medication market.
Acne Medication Market: Segmental Overview
The retinoid segment held the largest acne medication market share, based on therapeutic class, in 2022 and the same segment is anticipated to register a significant CAGR in the market during 2022-2030. Retinoids, which can be only bought with a doctor's prescription, contain vitamin A as a primary ingredient; they function similarly to retinol but they are far more potent and more successful in treating acne. Retinoids are available as oral capsules and topical therapies. Tretinoin, adapalene, and isotretinoin are well-known retinoids; the oral formulation of isotretinoin is sometimes referred to as Roaccutane. Retinoids are frequently prescribed in dosages of 0.1-1% for topical applications and 0.5-1 mg for oral applications per kilogram of patient weight.
Based on formulation, the acne medication market is classified into topical medication and oral medication. The topical medication segment held the largest share of the acne medication market in 2022. The same segment is further anticipated to record a significant CAGR in the market from 2022 to 2030. Topical formulations play a vital role in managing and treating acne, offering targeted delivery of active ingredients directly to the affected skin areas. Various types of topical acne medication include gel, cream, lotion, foam, and solution, each tailored to address specific acne concerns and skin types. These formulations commonly contain ingredients such as retinoids, benzoyl peroxide, salicylic acid, and antibiotics, each serving distinct roles in combating acne breakouts.
Based on type, the global acne medication market is classified into prescription medicines and over-the-counter medicines. The prescription medicines segment held a largest market share in 2022. Dermatologists or healthcare providers typically prescribe medications after a thorough assessment of the individual's acne type, severity, and responsiveness to previous treatments. Prescription acne medications encompass a range of options, including topical treatments, oral medications, combination therapies, and specialized formulations tailored to address specific acne concerns. Prescription medications are meant to offer targeted and potent solutions for individuals with moderate to severe forms of the condition.
The acne medication market is segmented into retail stores, pharmacies and drug stores, and others based on mode. In 2022, the pharmacies and drug stores segment held a larger market share. With their accessibility, privacy, and affordability (compared to private physicians), pharmacies and drug stores are vital sources of health services, supplies, and knowledge. Pharmacies and drug stores have gained recognition in numerous nations in recent years for their ability to enhance health by aiding in the management of a broad range of illnesses and medical conditions. Pharmacies and drug stores often have knowledgeable staff to guide customers on selecting the right acne medication based on individual skin types and concerns.
Acne Medication Market: Geographical Overview
In terms of geography, the scope of the acne medication market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In 2022, North America held the largest share of the global acne medication market.
Acne is a skin condition brought on by debris, oil, sebum, and dead skin cells clogging hair follicles. According to the American Academy of Dermatology, acne is the most prevalent illness in the US, up to 50 million Americans suffer from acne each year, making it the most common skin ailment in the country. The acne medication market in this country is projected to expand due to the increased incidence of acne in Americans and the subsequent launch of various innovative acne medications. Additionally, the growing focus on personal grooming, skin health, and external appearance fuels the demand for acne medications. Technological advancements and research have led to the development of innovative acne treatment products with improved efficacy and minimal side effects, contributing further to the acne medication market growth in the US, as people in this country are more willing to invest in high-quality products that deliver desired results.
Asia Pacific is estimated to register the highest CAGR during 2022-2030. This region is expected to record the fastest CAGR during the forecast period. In Asia Pacific, China is the largest market for acne medication. The acne medication market in China is propelled by various factors. Notably, the widespread adoption of AI-enabled telemedicine has revolutionized dermatological care, improving access to treatments and providing better personalization in the same. AIDERMA is China's first all-inclusive platform for AI-assisted skin patient diagnosis and therapy. Consultation, ongoing education, and supported diagnosis and therapy are the prime offerings of AIDERMA. More than 90 types of common skin illnesses are provided for assisted diagnosis and treatment. This claims to be a straightforward procedure that offers a diagnostic and potential course of action. More than 7,000 clinicians have registered for AIDDA, an application that allows doctors in China to diagnose psoriasis, eczema, and atopic dermatitis.
A few of the major primary and secondary sources referred to while preparing the report on the acne medication market are the World Bank Data, National Health Service (NHS), EMA (European Medicines Agency), and WHO (World Health Organization).
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Acne Medication Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Pricing Analysis of Topical and Oral Medication
- 4.4 Patient Population Undergoing Acne Treatment
5. Acne Medication Market - Key Market Dynamics
- 5.1 Acne Medication Market - Key Market Dynamics
- 5.2 Key Market Drivers
- 5.2.1 Increasing Prevalence of Severe Acne
- 5.2.2 Launch of Novel Drugs
- 5.3 Key Market Restraints
- 5.3.1 Side Effects Associated with Acne Medication
- 5.4 Key Market Opportunities
- 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
- 5.5 Future Trends
- 5.5.1 Upsurge in Need for Organic and Natural Treatments
- 5.6 Impact of Drivers and Restraints:
6. Acne Medication Market - Global Market Analysis
7. Acne Medication Market Analysis - by Therapeutic Class
- 7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
8. Acne Medication Market Analysis - by Formulation
- 8.1 Topical Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 8.2 Oral Medication
- 8.2.1 Overview
- 8.2.2 Oral Medication: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
9. Acne Medication Market Analysis - by Type
- 9.1 Prescription Medicine
- 9.1.1 Overview
- 9.1.2 Prescription Medicine: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 9.2 Over-the-Counter Medicine
- 9.2.1 Overview
- 9.2.2 Over-the-Counter Medicine: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
10. Acne Medication Market Analysis - by Acne Type
- 10.1 Non-Inflammatory Acne
- 10.1.1 Overview
- 10.1.2 Non-Inflammatory Acne: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 10.2 Inflammatory Acne
- 10.2.1 Overview
- 10.2.2 Inflammatory Acne: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11. Acne Medication Market Analysis - by Distribution Channel
- 11.1 Pharmacies and Drug Stores
- 11.1.1 Overview
- 11.1.2 Pharmacies and Drug Stores: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2 Retail Stores
- 11.2.1 Overview
- 11.2.2 Retail Stores: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3 E-Commerce
- 11.3.1 Overview
- 11.3.2 E-Commerce: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
12. Acne Medication Market - Geographical Analysis
- 12.1 Overview
- 12.2 North America
- 12.2.1 Overview
- 12.2.2 North America: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.2.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.2.2.2 North America: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.2.2.3 North America: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.2.2.4 North America: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.2.2.5 North America: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.2.3 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.2.3.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.2.3.2 US
- 12.2.3.3 US: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.3.3.1 US: Acne Medication Market Breakdown, by Therapeutic Class
- 12.2.3.3.2 US: Acne Medication Market Breakdown, by Formulation
- 12.2.3.3.3 US: Acne Medication Market Breakdown, by Type
- 12.2.3.3.4 US: Acne Medication Market Breakdown, by Acne Type
- 12.2.3.3.5 US: Acne Medication Market Breakdown, by Distribution Channel
- 12.2.3.4 Canada
- 12.2.3.5 Canada: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.3.5.1 Canada: Acne Medication Market Breakdown, by Therapeutic Class
- 12.2.3.5.2 Canada: Acne Medication Market Breakdown, by Formulation
- 12.2.3.5.3 Canada: Acne Medication Market Breakdown, by Type
- 12.2.3.5.4 Canada: Acne Medication Market Breakdown, by Acne Type
- 12.2.3.5.5 Canada: Acne Medication Market Breakdown, by Distribution Channel
- 12.2.3.6 Mexico
- 12.2.3.7 Mexico: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.3.7.1 Mexico: Acne Medication Market Breakdown, by Therapeutic Class
- 12.2.3.7.2 Mexico: Acne Medication Market Breakdown, by Formulation
- 12.2.3.7.3 Mexico: Acne Medication Market Breakdown, by Type
- 12.2.3.7.4 Mexico: Acne Medication Market Breakdown, by Acne Type
- 12.2.3.7.5 Mexico: Acne Medication Market Breakdown, by Distribution Channel
- 12.3 Europe
- 12.3.1 Overview
- 12.3.2 Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.2.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.3.2.2 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.3.2.3 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.3.2.4 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.3.2.5 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.3.3 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.3.3.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.3.3.2 Germany
- 12.3.3.3 Germany: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.3.2 Germany: Acne Medication Market Breakdown, by Formulation
- 12.3.3.3.3 Germany: Acne Medication Market Breakdown, by Type
- 12.3.3.3.4 Germany: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.4 France
- 12.3.3.5 France: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.5.2 France: Acne Medication Market Breakdown, by Formulation
- 12.3.3.5.3 France: Acne Medication Market Breakdown, by Type
- 12.3.3.5.4 France: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.5.5 France: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.6 UK
- 12.3.3.7 UK: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.7.2 UK: Acne Medication Market Breakdown, by Formulation
- 12.3.3.7.3 UK: Acne Medication Market Breakdown, by Type
- 12.3.3.7.4 UK: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.8 Italy
- 12.3.3.9 Italy: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.9.2 Italy: Acne Medication Market Breakdown, by Formulation
- 12.3.3.9.3 Italy: Acne Medication Market Breakdown, by Type
- 12.3.3.9.4 Italy: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.10 Spain
- 12.3.3.11 Spain: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.11.2 Spain: Acne Medication Market Breakdown, by Formulation
- 12.3.3.11.3 Spain: Acne Medication Market Breakdown, by Type
- 12.3.3.11.4 Spain: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.12 Rest of Europe
- 12.3.3.13 Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation
- 12.3.3.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type
- 12.3.3.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel
- 12.4 Asia Pacific
- 12.4.1 Asia Pacific Acne Medication Market Overview
- 12.4.2 Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.2.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.4.2.2 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.4.2.3 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.4.2.4 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.4.2.5 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.4.3 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.4.3.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.4.3.2 China
- 12.4.3.3 China: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.3.1 China: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.3.2 China: Acne Medication Market Breakdown, by Formulation
- 12.4.3.3.3 China: Acne Medication Market Breakdown, by Type
- 12.4.3.3.4 China: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.3.5 China: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.4 Japan
- 12.4.3.5 Japan: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.5.1 Japan: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.5.2 Japan: Acne Medication Market Breakdown, by Formulation
- 12.4.3.5.3 Japan: Acne Medication Market Breakdown, by Type
- 12.4.3.5.4 Japan: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.5.5 Japan: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.6 India
- 12.4.3.7 India: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.7.1 India: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.7.2 India: Acne Medication Market Breakdown, by Formulation
- 12.4.3.7.3 India: Acne Medication Market Breakdown, by Type
- 12.4.3.7.4 India: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.7.5 India: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.8 Australia
- 12.4.3.9 Australia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.9.1 Australia: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.9.2 Australia: Acne Medication Market Breakdown, by Formulation
- 12.4.3.9.3 Australia: Acne Medication Market Breakdown, by Type
- 12.4.3.9.4 Australia: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.9.5 Australia: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.10 South Korea
- 12.4.3.11 South Korea: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.11.1 South Korea: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.11.2 South Korea: Acne Medication Market Breakdown, by Formulation
- 12.4.3.11.3 South Korea: Acne Medication Market Breakdown, by Type
- 12.4.3.11.4 South Korea: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.11.5 South Korea: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.12 Rest of Asia Pacific
- 12.4.3.13 Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.13.1 Rest of Asia Pacific: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.13.2 Rest of Asia Pacific: Acne Medication Market Breakdown, by Formulation
- 12.4.3.13.3 Rest of Asia Pacific: Acne Medication Market Breakdown, by Type
- 12.4.3.13.4 Rest of Asia Pacific: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.13.5 Rest of Asia Pacific: Acne Medication Market Breakdown, by Distribution Channel
- 12.5 Middle East and Africa
- 12.5.1 Overview
- 12.5.2 Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030
- 12.5.2.1 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.5.2.2 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.5.2.3 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.5.2.4 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.5.2.5 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.5.3 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.5.3.1 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.5.3.2 Saudi Arabia
- 12.5.3.3 Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.3.1 Saudi Arabia: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.3.2 Saudi Arabia: Acne Medication Market Breakdown, by Formulation
- 12.5.3.3.3 Saudi Arabia: Acne Medication Market Breakdown, by Type
- 12.5.3.3.4 Saudi Arabia: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.3.5 Saudi Arabia: Acne Medication Market Breakdown, by Distribution Channel
- 12.5.3.4 South Africa
- 12.5.3.5 South Africa: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.5.1 South Africa: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.5.2 South Africa: Acne Medication Market Breakdown, by Formulation
- 12.5.3.5.3 South Africa: Acne Medication Market Breakdown, by Type
- 12.5.3.5.4 South Africa: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.5.5 South Africa: Acne Medication Market Breakdown, by Distribution Channel
- 12.5.3.6 UAE
- 12.5.3.7 UAE: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.7.1 UAE: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.7.2 UAE: Acne Medication Market Breakdown, by Formulation
- 12.5.3.7.3 UAE: Acne Medication Market Breakdown, by Type
- 12.5.3.7.4 UAE: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.7.5 UAE: Acne Medication Market Breakdown, by Distribution Channel
- 12.5.3.8 Rest of Middle East and Africa
- 12.5.3.9 Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.9.1 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.9.2 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Formulation
- 12.5.3.9.3 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Type
- 12.5.3.9.4 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.9.5 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Distribution Channel
- 12.6 South and Central America
- 12.6.1 Overview
- 12.6.2 South and Central America: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.1 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.6.2.2 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.6.2.3 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.6.2.4 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.6.2.5 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.6.2.6 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.6.2.7 Brazil
- 12.6.2.8 Brazil: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.8.1 Brazil: Acne Medication Market Breakdown, by Therapeutic Class
- 12.6.2.8.2 Brazil: Acne Medication Market Breakdown, by Formulation
- 12.6.2.8.3 Brazil: Acne Medication Market Breakdown, by Type
- 12.6.2.8.4 Brazil: Acne Medication Market Breakdown, by Acne Type
- 12.6.2.8.5 Brazil: Acne Medication Market Breakdown, by Distribution Channel
- 12.6.2.9 Argentina
- 12.6.2.10 Argentina: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.10.1 Argentina: Acne Medication Market Breakdown, by Therapeutic Class
- 12.6.2.10.2 Argentina: Acne Medication Market Breakdown, by Formulation
- 12.6.2.10.3 Argentina: Acne Medication Market Breakdown, by Type
- 12.6.2.10.4 Argentina: Acne Medication Market Breakdown, by Acne Type
- 12.6.2.10.5 Argentina: Acne Medication Market Breakdown, by Distribution Channel
- 12.6.2.11 Rest of South and Central America
- 12.6.2.12 Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.12.1 Rest of South and Central America: Acne Medication Market Breakdown, by Therapeutic Class
- 12.6.2.12.2 Rest of South and Central America: Acne Medication Market Breakdown, by Formulation
- 12.6.2.12.3 Rest of South and Central America: Acne Medication Market Breakdown, by Type
- 12.6.2.12.4 Rest of South and Central America: Acne Medication Market Breakdown, by Acne Type
- 12.6.2.12.5 Rest of South and Central America: Acne Medication Market Breakdown, by Distribution Channel
13. Acne Medication Market- Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies in Acne Medication Market
- 13.3 Organic Growth Strategies
- 13.3.1 Overview
- 13.4 Inorganic Growth Strategies
- 13.4.1 Overview
- 13.5 Product Offered by Farmapiel vs Other Companies Acne Products
14. Company Profiles
- 14.1 Teva Pharmaceutical Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Mayne Pharma Group Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Almirall SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Johnson & Johnson
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Sun Pharmaceutical Industries Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Bausch Health Companies Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Centro Internacional de Cosmiatria SA de CV
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 Galderma SA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Pfizer Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 GSK Plc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
- 14.11 Viatris Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
- 14.12 Somar Sapi De CV
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments
- 14.13 Pierre Fabre SA
- 14.13.1 Key Facts
- 14.13.2 Business Description
- 14.13.3 Products and Services
- 14.13.4 Financial Overview
- 14.13.5 SWOT Analysis
- 14.13.6 Key Developments
- 14.14 Carnot Technologies
- 14.14.1 Key Facts
- 14.14.2 Business Description
- 14.14.3 Products and Services
- 14.14.4 Financial Overview
- 14.14.5 SWOT Analysis
- 14.14.6 Key Developments
- 14.15 Italmex SA
- 14.15.1 Key Facts
- 14.15.2 Business Description
- 14.15.3 Products and Services
- 14.15.4 Financial Overview
- 14.15.5 SWOT Analysis
- 14.15.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms
